Illumina Inc (ILMN)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.90 (+0.61%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Illumina Inc (ILMN)
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Key Insights

Critical company metrics and information
  • Share Price

    $147.53
  • Market Cap

    $23.40 Billion
  • Total Outstanding Shares

    158.60 Million Shares
  • Total Employees

    9,300
  • Dividend

    No dividend
  • IPO Date

    July 28, 2000
  • SIC Description

    Laboratory Analytical Instruments
  • Homepage

    https://www.illumina.com

Historical Stock Splits

If you bought 1 share of ILMN before September 23, 2008, you'd have 2 shares today.
Execution DateSplit Amount
September 23, 20082-for-1

Cash Flow Statement

September 30, 2023 to September 29, 2024
MetricValue
Net Cash Flow From Financing Activities$-550.00 Million
Net Cash Flow, Continuing$-68.00 Million
Net Cash Flow$-58.00 Million
Net Cash Flow From Financing Activities, Continuing$-550.00 Million
Exchange Gains/Losses$10.00 Million
Net Cash Flow From Investing Activities, Continuing$-215.00 Million
Net Cash Flow From Operating Activities$697.00 Million
Net Cash Flow From Investing Activities$-215.00 Million
Net Cash Flow From Operating Activities, Continuing$697.00 Million

Income Statement

September 30, 2023 to September 29, 2024
MetricValue
Basic Average Shares$477.00 Million
Other Operating Expenses$1.43 Billion
Research and Development$1.26 Billion
Benefits Costs and Expenses$5.92 Billion
Nonoperating Income/Loss$-361.00 Million
Diluted Average Shares$478.00 Million
Operating Income/Loss$-1.17 Billion
Income/Loss From Continuing Operations After Tax$-1.59 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Net Income/Loss Attributable To Parent$-1.59 Billion
Basic Earnings Per Share$-9.95
Operating Expenses$3.98 Billion
Revenues$4.39 Billion
Diluted Earnings Per Share$-9.96
Preferred Stock Dividends And Other Adjustments$0.00
Net Income/Loss Available To Common Stockholders, Basic$-1.59 Billion
Income/Loss From Continuing Operations Before Tax$-1.54 Billion
Gross Profit$2.81 Billion
Costs And Expenses$5.92 Billion
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Cost Of Revenue$1.58 Billion
Selling, General, and Administrative Expenses$1.31 Billion
Income Tax Expense/Benefit$52.00 Million
Net Income/Loss$-1.59 Billion

Balance Sheet

September 30, 2023 to September 29, 2024
MetricValue
Inventory$574.00 Million
Current Liabilities$975.00 Million
Wages$237.00 Million
Fixed Assets$832.00 Million
Liabilities And Equity$6.01 Billion
Intangible Assets$305.00 Million
Liabilities$3.89 Billion
Assets$6.01 Billion
Equity Attributable To Parent$2.13 Billion
Equity$2.13 Billion
Accounts Payable$191.00 Million
Equity Attributable To Noncontrolling Interest$0.00
Other Current Liabilities$547.00 Million
Other Current Assets$1.80 Billion
Current Assets$2.37 Billion
Noncurrent Assets$3.64 Billion
Noncurrent Liabilities$2.91 Billion
Other Non-current Assets$2.50 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.